hourglass with coronaviruses instead of sand
Omicron Half as Likely to Lead to Long COVID as Delta: Study
People who were vaccinated at least six months prior to infection had the lowest risk of lasting symptoms in a UK study.
Omicron Half as Likely to Lead to Long COVID as Delta: Study
Omicron Half as Likely to Lead to Long COVID as Delta: Study

People who were vaccinated at least six months prior to infection had the lowest risk of lasting symptoms in a UK study.

People who were vaccinated at least six months prior to infection had the lowest risk of lasting symptoms in a UK study.

ABOVE: © ISTOCK.COM, Floriana
coronavirus
Round white pills on a wooden surface
No Reduction in COVID-19 Hospitalizations, Deaths with Ivermectin
Catherine Offord | Jun 13, 2022
The ACTIV-6 trial reports that people who took the drug for three days may have spent slightly less time feeling unwell with SARS-CoV-2, but fails to find differences in disease progression between the treatment and placebo groups.
Spraying spray bottle
Nasal Vaccines Are Commercially High Risk, Perhaps High Reward
Jef Akst | Jun 13, 2022
Dozens of intranasally delivered vaccines targeting SARS-CoV-2 are in development. Could they pave the way for widespread nasal vaccination in the future?
Characterizing Proteolysis During SARS-CoV-2 Infection
Characterizing Proteolysis During SARS-CoV-2 Infection
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | Nov 2, 2021
Edward Emmott will discuss mass spectrometry approaches to understand proteolysis during viral infection and their use in developing targeted strategies for COVID-19 treatment.
Open orange pill bottle with rounded white pills
What’s the Evidence for Fluvoxamine in COVID-19? 
Catherine Offord | May 20, 2022
The US FDA’s decision not to grant an emergency use authorization for the antidepressant as a COVID-19 treatment highlights a lack of consensus among researchers about how to interpret clinical data on the drug.
Woman in face shield and blue gown taking cotton swab of patient's mouth while patient sits inside of car
What You Should Know About New Omicron Subvariants
Natalia Mesa | May 17, 2022
The presence and spread of new, more-infectious and immune-evading variants show that the coronavirus is not done mutating.
Understanding COVID’s Long Game
Understanding COVID’s Long Game
The Creative Services Team in collaboration with Cayman Chemical | Oct 21, 2021
Floyd Chilton and Thomas Bumol shine light on the pathways that SARS-CoV-2 hijacks to cause disease.
Group of cells stained in either blue or green in a black background.
Diabetes Marker Linked to COVID-19 Severity in Mice
Alejandra Manjarrez | May 16, 2022
A sugar that’s less abundant in the blood of people with diabetes binds to SARS-CoV-2’s spike protein and disrupts the virus’s ability to fuse with cells.  
Brick building with tall windows and white letters out front that say "Food and Drug Administration"
FDA Limits Use of J&J Vaccine, Citing Safety Concerns
Natalia Mesa | May 6, 2022
US adults are now only eligible for the vaccine under certain circumstances.
800x560-october-20-2021
Keeping Pace With SARS-CoV-2 Evolution
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | Sep 29, 2021
Eugene Koonin and Eric Niederkofler discuss novel technologies to improve viral mutation surveillance.
hands of a person checking their blood glucose level with a monitor
Growing Evidence Ties COVID-19 to Diabetes Risk
Bianca Nogrady | May 3, 2022
Studies suggest SARS-CoV-2 infection could trigger the development of diabetes in some people, even those with no other risk factors.
Liver glowing red underneath human torso
Mysterious Hepatitis Cases Reported in Young Children
Natalia Mesa | Apr 18, 2022
Officials have ruled out known hepatitis viruses as the cause of a rash of illnesses in Europe and the US.
800x560-misherlock-0916
A New COVID-19 Spit Test Is as Easy as 1-2-3
Roni Dengler, PhD | Aug 16, 2021
A device smaller than two stacked decks of cards can reliably detect and discriminate between SARS-CoV-2 variants in spit in less than an hour with results that glow.
a research sailboat with white sails inscribed with "tara ocean" traverses a body of water with small, rocky islands in the background
Q&A: Thousands of RNA Viruses Newly Discovered in Ocean Water
Dan Robitzski | Apr 7, 2022
The Scientist spoke with Ohio State University microbiologist Matthew Sullivan about a recent expedition that identified thousands of RNA viruses from water samples and cataloged them into novel phylogenic groups.
President Biden meeting with a group of people in the oval office
Biden Orders More Research on Long COVID
Christie Wilcox | Apr 6, 2022
A new presidential memorandum requires the Department of Health and Human Services to coordinate a government-wide push to generate a research action plan for the condition.
Approaches to Processing SARS-CoV-2 Samples for RNA Detection
The Scientist Creative Services Team in collaboration with MilliporeSigma | May 10, 2021
Discover new RNA extraction and purification strategies and how they enable reliable and sensitive viral detection.
A micrograph from the first US case of COVID-19, with SARS-CoV-2 virus particles in blue
SARS-CoV-2 Can Spread Via Cell-to-Cell Transmission
Catherine Offord | Apr 4, 2022
The virus’s ability to slip directly from one cell to another may help it avoid some of the body’s immune responses.
Illustration of the Earth heating up
Opinion: Climate Change Is Dangerous to Your Health
Mark Kessel, Rick Elbaum | Apr 4, 2022
In addition to causing more frequent natural disasters, global warming can have long-term health effects, which range from heat stress to mosquito-borne disease.
How Infectious Diseases Affect the Brain
The Scientist Creative Services Team | Apr 8, 2021
From a loss of taste to dementia, infectious agents cause an array of neurological symptoms.
Vector abstract world around coronavirus macro illustration.
Living the Life Pandemic
Bob Grant | Mar 16, 2022
The first part of 2022 is giving us a glimpse of humanity’s future relationship with COVID-19.